Rohto Pharmaceutical Co.,Ltd. (TYO: 4527)

Rohto Pharmaceutical Co.,Ltd. Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	64,502	89,210	79,951	72,791	52,964	45,307
Cash & Short-Term Investments	64,502	89,210	79,951	72,791	52,964	45,307
Cash Growth	-18.70%	11.58%	9.84%	37.43%	16.90%	19.68%
Receivables	68,530	69,115	60,656	51,682	47,865	50,416
Inventory	61,859	46,657	41,062	33,527	27,925	30,625
Other Current Assets	10,004	9,777	8,577	6,306	4,317	3,760
Total Current Assets	204,895	214,759	190,246	164,306	133,071	130,108
Property, Plant & Equipment	88,524	68,607	66,182	62,839	49,790	48,460
Long-Term Investments	56,871	43,731	32,629	27,471	27,425	24,024
Goodwill	49,531	2,285	2,564	2,954	4,014	3,373
Other Intangible Assets	8,437	6,932	6,997	6,338	3,521	1,945
Long-Term Deferred Tax Assets	-	3,869	5,371	5,297	4,606	4,292
Other Long-Term Assets	2	2	1	2	2	2
Total Assets	408,260	346,175	309,677	274,627	225,790	215,301
Accounts Payable	24,020	21,123	18,718	16,269	11,330	14,243
Accrued Expenses	24,926	25,720	24,362	19,354	25,208	28,312
Short-Term Debt	24,300	5,304	4,177	8,033	2,312	2,105
Current Income Taxes Payable	5,620	6,643	6,230	3,185	6,138	5,728
Other Current Liabilities	32,280	28,297	26,675	24,647	11,483	11,729
Total Current Liabilities	111,146	87,087	80,162	71,488	56,471	62,117
Long-Term Debt	20,236	5,190	7,516	13,350	5,787	5,190
Long-Term Deferred Tax Liabilities	-	1,597	1,173	1,450	639	373
Other Long-Term Liabilities	9,785	2,720	2,645	1,177	2,831	3,274
Total Liabilities	143,915	99,142	94,600	90,797	69,179	75,271
Common Stock	6,504	6,504	6,504	6,504	6,504	6,504
Additional Paid-In Capital	-	4,516	5,292	5,787	5,661	5,661
Retained Earnings	214,342	209,399	184,005	162,195	145,511	131,985
Treasury Stock	-4,939	-4,939	-4,938	-4,936	-4,936	-4,935
Comprehensive Income & Other	37,133	30,843	18,706	8,737	3,167	66
Total Common Equity	253,040	246,323	209,569	178,287	155,907	139,281
Minority Interest	11,305	710	5,508	5,543	704	749
Shareholders' Equity	264,345	247,033	215,077	183,830	156,611	140,030
Total Liabilities & Equity	408,260	346,175	309,677	274,627	225,790	215,301
Total Debt	44,536	10,494	11,693	21,383	8,099	7,295
Net Cash (Debt)	19,966	78,716	68,258	51,408	44,865	38,012
Net Cash Growth	-71.21%	15.32%	32.78%	14.58%	18.03%	16.29%
Net Cash Per Share	87.26	344.04	298.33	224.69	196.09	166.15
Filing Date Shares Outstanding	228.14	228.14	228.14	228.14	228.14	228.14
Total Common Shares Outstanding	228.14	228.14	228.14	228.14	228.14	228.14
Working Capital	93,749	127,672	110,084	92,818	76,600	67,991
Book Value Per Share	1109.15	1079.71	918.60	781.48	683.38	610.51
Tangible Book Value	195,072	237,106	200,008	168,995	148,372	133,963
Tangible Book Value Per Share	855.06	1039.31	876.69	740.75	650.35	587.20

Source: S&P Capital IQ. Standard template. Financial Sources.